Detection of Dural Metastases Before the Onset of Clinical Symptoms by 16α-[18F]Fluoro-17β-Estradiol PET in a Patient With Estrogen Receptor-Positive Breast Cancer

被引:8
作者
Boers, Jorianne [1 ]
Schroder, Carolina P. [1 ]
Hospers, Geke A. P. [1 ]
de Vries, Erik F. J. [2 ]
Glaudemans, Andor W. J. M. [2 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands
关键词
F-18]-FES PET; brain metastases; breast cancer; estrogen receptor;
D O I
10.1097/RLU.0000000000003382
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We offer an illustrative case about estrogen receptor (ER) imaging (also known as 16 alpha-[F-18]fluoro-17 beta-estradiol ([F-18]-FES) PET) and the detection of metastatic lesions in the dural region. We present a case of a woman with ER-positive metastatic breast cancer and high [F-18]-FES uptake in the dural region on PET imaging, without associated clinical symptoms. These lesions were missed on [F-18]-FDG PET because of physiological [F-18]-FDG uptake in the brain. This case highlighted some difficulties in the interpretation of imaging of brain metastases and demonstrated the added value of [F-18]-FES PET imaging. [F-18]-FES PET could be used to prove the presence of ER-positive metastases in the brain.
引用
收藏
页码:e165 / e167
页数:3
相关论文
共 8 条
[1]  
[Anonymous], [No title captured]
[2]   Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition [J].
Boers, Jorianne ;
Venema, Clasina M. ;
de Vries, Erik F. J. ;
Glaudemans, Andor W. J. M. ;
Kwee, Thomas C. ;
Schuuring, Ed ;
Martens, John W. M. ;
Elias, Sjoerd G. ;
Hospers, Geke A. P. ;
Schroder, Carolina P. .
EUROPEAN JOURNAL OF CANCER, 2020, 126 :11-20
[3]   Diagnostic accuracy and safety of 16α-[18F]fluoro-17β-oestradiol PET-CT for the assessment of oestrogen receptor status in recurrent or metastatic lesions in patients with breast cancer: a prospective cohort study [J].
Chae, Sun Young ;
Ahn, Sei Hyun ;
Kim, Sung-Bae ;
Han, Sangwon ;
Lee, Suk Hyun ;
Oh, Seung Jun ;
Lee, Sang Ju ;
Kim, Hee Jeong ;
Ko, Beom Seok ;
Lee, Jong Won ;
Son, Byung Ho ;
Kim, Jisun ;
Ahn, Jin-Hee ;
Jung, Kyung Hae ;
Kim, Jeong Eun ;
Kim, Seog-Young ;
Choi, Woo Jung ;
Shin, Hee Jung ;
Gong, Gyungyub ;
Lee, Hyo Sang ;
Lee, Jung Bok ;
Moon, Dae Hyuk .
LANCET ONCOLOGY, 2019, 20 (04) :546-555
[4]   18F-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients [J].
Nienhuis, Hilde H. ;
van Kruchten, Michel ;
Elias, Sjoerd G. ;
Glaudemans, Andor W. J. M. ;
de Vries, Erik F. J. ;
Bongaerts, Alfons H. H. ;
Schroeder, Carolien P. ;
de Vries, Elisabeth G. E. ;
Hospers, Geke A. P. .
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (08) :1212-1218
[5]   PET imaging of oestrogen receptors in patients with breast cancer [J].
van Kruchten, Michel ;
de Vries, Elisabeth G. E. ;
Brown, Myles ;
de Vries, Erik F. J. ;
Glaudemans, Andor W. J. M. ;
Dierckx, Rudi A. J. O. ;
Schroder, Carolien P. ;
Hospers, Geke A. P. .
LANCET ONCOLOGY, 2013, 14 (11) :E465-E475
[6]   PET Imaging of Estrogen Receptors as a Diagnostic Tool for Breast Cancer Patients Presenting with a Clinical Dilemma [J].
van Kruchten, Michel ;
Glaudemans, Andor W. J. M. ;
de Vries, Erik F. J. ;
Beets-Tan, Regina G. H. ;
Schroder, Carolien P. ;
Dierckx, Rudi A. ;
de Vries, Elisabeth G. E. ;
Hospers, Geke A. P. .
JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (02) :182-190
[7]   18F-FES PET Has Added Value in Staging and Therapy Decision Making in Patients With Disseminated Lobular Breast Cancer [J].
Venema, Clasina ;
de Vries, Erik ;
Glaudemans, Andor ;
Poppema, Boelo ;
Hospers, Geke ;
Schroder, Carolina .
CLINICAL NUCLEAR MEDICINE, 2017, 42 (08) :612-614
[8]   Recommendations and Technical Aspects of 16a-[18F]Fluoro-17β-Estradiol PET to Image the Estrogen Receptor In Vivo The Groningen Experience [J].
Venema, Clasina M. ;
Apollonio, Giulia ;
Hospers, Geke A. P. ;
Schroeder, Carolina P. ;
Dierckx, Rudi A. J. O. ;
de Vries, Erik F. J. ;
Glaudemans, Andor W. J. M. .
CLINICAL NUCLEAR MEDICINE, 2016, 41 (11) :844-851